This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Chia-Jung Yu: Innovator in Viral Protein Research
Introduction
Chia-Jung Yu is a notable inventor based in Chang Gung Village, Kwei-San, Tao-Yuan, Taiwan. He has made significant contributions to the field of viral protein research, particularly in relation to coronavirus infections. His innovative work has led to the development of a patent that addresses critical aspects of viral diagnostics and treatment.
Latest Patents
Chia-Jung Yu holds a patent for a viral protein, specifically an isolated polypeptide containing SEQ ID NO: 1 or an immunogenic fragment thereof. The patent also includes an isolated nucleic acid encoding the polypeptide or containing a sequence at least 70% identical to SEQ ID NO: 3. This invention encompasses related expression vectors, host cells, and antibodies. Furthermore, it outlines methods for producing the polypeptide, diagnosing coronavirus infection, and identifying test compounds for treating such infections. He has 1 patent to his name.
Career Highlights
Throughout his career, Chia-Jung Yu has focused on advancing the understanding of viral proteins and their implications in health. His research has been pivotal in developing diagnostic tools and potential treatments for viral infections, particularly in the context of emerging diseases.
Collaborations
Chia-Jung Yu has collaborated with esteemed colleagues, including Fang-Jen Lee and Ming-Fu Chang. These partnerships have enhanced the scope and impact of his research, contributing to advancements in the field of virology.
Conclusion
Chia-Jung Yu is a prominent figure in the realm of viral protein research, with a patent that showcases his innovative approach to addressing coronavirus infections. His work continues to influence the scientific community and offers hope for future advancements in viral diagnostics and treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile